2025 DDC Symposium at UC Riverside
%20-001.png)
Confirmed speakers:
Scott Lokey (UC Santa Cruz)
David Shackelford (UCLA)
Kyle Fink (UC Davis)
Adam Renslo (UC San Francisco)
Jim Hurley (UC Berkeley)
Melanie Cocco (UC Irvine)
Maurizio Pellecchia (UC Riverside)
Location:
UC Riverside
School of Medicine
Education II Building, room 205
900 University Ave.
Riverside 92521
​

SYMPOSIUM AGENDA
9-9:20am - Registration. Posters. Light Refreshments.
​
9:30-9:40am - Welcome and Introduction to the Symposium
Maurizio Pellecchia, PhD., UC Riverside
Rodolfo Torres, PhD., VC Research & Economic Development, UC Riverside
​
9:40-9:50am - UC Drug Discovery Consortium: Introduction & Announcements
Michael A. Rogawski, PhD., UC Davis
​
Session I chair: Melanie Cocco, UC Irvine
​
9:50-10:15am - "Spatial Mapping of Organelle Networks and Metabolism in Lung Cancer"
David Shackelford, PhD., UC Los Angeles
​
10:15-10:40am - "The Development of Targeted Epigenetic Editors for the Treatment of Genetic Epilepsy"
Kyle Fink, PhD., UC Davis
​
10:40-11:05am - "Discovery of Antiviral Leads with Superior Efficacy in SARS-CoV2
and MERS Infection Models"
Adam Renslo, PhD., UC San Francisco
​
11:05-11:30am - "Massively Parallel, Single-Molecule Assessment of Synthetic Fidelity
and Drug-like Properties in DNA-encoded Library"
Scott Lokey, PhD., UC Santa Cruz
​
11:30am-1:30pm - Lunch and Poster Presentations (optional walks to either the botanical gardens or the MRB1 Incubator Laboratory Space)
​
Session II chairs: UCDDC EC
UC Translates round table session: From academic research to spin-off biotech companies
​
1:30-1:35pm - Armida Labs, UC Riverside spin-off
Carlo Baggio, PhD., Co-founder and CTO
​
1:35-1:40pm - Eicosis, UC Davis spin-off
Cindy McReynolds, PhD., CEO
​
1:40-1:45pm - Zenith Therapeutics, UC Berkeley spin-off
Julia Schaletzky, PhD., Co-founder
​
1:45-1:50pm - Amplyx Pharmaceuticals, UC San Francisco spin-off
Jason Gestwicki, PhD., Co-founder
​
1:50-1:55pm - Unnatural Products - UC Santa Cruz spin-off
Cameron Pye, PhD., Co-founder and CSO & Josh Schwochert, PhD., Co-founder and CTO
​
1:55-2:00pm - Ocean Therapeutics - UC San Diego spin-off
William Fenical, PhD., Founder
​
2:00-2:30pm - UC spin-off panel/roundtable discussion
​
2:30-2:55pm - Afternoon Break and Poster presentations
​
Session III chair: Robert Damoiseaux, PhD., UC Los Angeles
​
2:55-3:20pm - "The ESCRT system of membrane remodeling as a new target for drug discovery"
Jim Hurley, PhD., UC Berkeley
3:20-3:45pm - "Drugs Designed to Treat Sickle Cell Disease: Mechanisms of Binding to Hemoglobin"
Melanie Cocco, PhD., UC Irvine
3:45-4:10pm - "Covalent drug discovery targeting His/Lys or Tyr residues"
Maurizio Pellecchia, PhD., UC Riverside
4:10-4:15pm - Poster Awards
Maurizio Pellecchia, PhD. and the UCDDC EC
Keynote presentation Chair, Michael Gilson, PhD., UC San Diego
4:15-5:00pm - "Angiogenesis: Basic Biology and Therapeutic Opportunities"
Keynote speaker, Napoleone Ferrara, MD., UC San Diego
5:00-5:30pm - Light refreshments and adjourn